Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

The test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.

Among other topics, conversations at the meeting focused on new methods for measuring proteins as well as opportunities for automation and AI.

Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

In this feature, we explore the promise of next generation proteomics in modern healthcare and drug discovery.

Social isolation and loneliness scores were calculated for each individual and a high-throughput proteomics platform from Olink was used to analyze the blood samples and identify any proteins ...

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.